Top

Published in:

01-02-2012 | Epidemiology

Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression

Authors: Xuezheng Sun, Patricia Casbas-Hernandez, Carol Bigelow, Liza Makowski, D. Joseph Jerry, Sallie Smith Schneider, Melissa A. Troester

Published in: Breast Cancer Research and Treatment | Issue 3/2012

Abstract

Activation of inflammatory pathways is one plausible mechanism underlying the association between obesity and increased breast cancer risk. However, macrophage infiltration and local biomarkers of inflammation in breast adipose tissue have seldom been studied in association with obesity. Gene expression profiles of normal breast tissue from reduction mammoplasty patients were evaluated by whole genome microarrays to identify patterns associated with obesity status (normal-weight, body mass index (BMI) <25; overweight, BMI 25–29.9; obese, BMI ≥30). The presence of macrophage-enriched inflammatory loci with immunopositivity for CD68 protein was evaluated by immunohistochemistry (IHC). After adjusting for confounding by age, 760 genes were differentially expressed (203 up and 557 down; FDR = 0.026) between normal-weight and obese women. Gene ontology analysis suggested significant enrichment for pathways involving IL-6, IL-8, CCR5 signaling in macrophages and RXRα and PPARα activation, consistent with a pro-inflammatory state and suggestive of macrophage infiltration. Gene set enrichment analysis also demonstrated that the genomic signatures of monocytes and macrophages were over-represented in the obese group with FDR of 0.08 and 0.13, respectively. Increased macrophage infiltration was confirmed by IHC, which showed that the breast adipose tissue of obese women had higher average macrophage counts (mean = 8.96 vs. 3.56 in normal-weight women) and inflammatory foci counts (mean = 4.91 vs. 2.67 in normal-weight women). Obesity is associated with local inflammation and macrophage infiltration in normal human breast adipose tissues. Given the role of macrophages in carcinogenesis, these findings have important implications for breast cancer etiology and progression.

Available only for authorised users

Carmichael AR, Bates T (2004) Obesity and breast cancer: a review of the literature. Breast 13:85–92. doi:10.1016/j.breast.2003.03.001 PubMedCrossRef

Huang Z, Hankinson SE, Colditz GA et al (1997) Dual effects of weight and weight gain on breast cancer risk. JAMA 278:1407–1411PubMedCrossRef

Renehan AG, Tyson M, Egger M et al (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569–578. doi:10.1016/S0140-6736(08)60269-X PubMedCrossRef

Ursin G, Longnecker MP, Haile RW et al (1995) A meta-analysis of body mass index and risk of premenopausal breast cancer. Epidemiology 6:137–141PubMedCrossRef

Yang XR, Chang-Claude J, Goode EL et al (2011) Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the breast cancer association consortium studies. J Natl Cancer Inst 103:250–263. doi:10.1093/jnci/djq526 PubMedCrossRef

Ahima RS (2006) Adipose tissue as an endocrine organ. Obesity (Silver Spring) 14(5):242S–249S. doi:10.1038/oby.2006.317 CrossRef

Wozniak SE, Gee LL, Wachtel MS et al (2009) Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci 54:1847–1856. doi:10.1007/s10620-008-0585-3 PubMedCrossRef

Endogenous Hormones and BreastCancerCollaborative Group, Key TJ, Appleby PN et al (2010) Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 11:530–542. doi:10.1016/S1470-2045(10)70095-4 PubMedCrossRef

Tsugane S, Inoue M (2010) Insulin resistance and cancer: epidemiological evidence. Cancer Sci 101:1073–1079. doi:10.1111/j.1349-7006.2010.01521.x PubMedCrossRef

10.

Cleary MP, Grossmann ME (2009) Minireview: obesity and breast cancer: the estrogen connection. Endocrinology 150:2537–2542. doi:10.1210/en.2009-0070 PubMedCrossRef

11.

Jarde T, Perrier S, Vasson MP et al (2011) Molecular mechanisms of leptin and adiponectin in breast cancer. Eur J Cancer 47:33–43. doi:10.1016/j.ejca.2010.09.005 PubMedCrossRef

12.

Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548–2556. doi:10.1210/jc.2004-0395 PubMedCrossRef

13.

Bluher M (2009) Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diabetes 117:241–250. doi:10.1055/s-0029-1192044 PubMedCrossRef

14.

Mantovani A, Allavena P, Sica A et al (2008) Cancer-related inflammation. Nature 454:436–444. doi:10.1038/nature07205 PubMedCrossRef

15.

Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860–867. doi:10.1038/nature01322 PubMedCrossRef

16.

Allavena P, Garlanda C, Borrello MG et al (2008) Pathways connecting inflammation and cancer. Curr Opin Genet Dev 18:3–10. doi:10.1016/j.gde.2008.01.003 PubMedCrossRef

17.

Sansone P, Bromberg J (2011) Environment, inflammation, and cancer. Curr Opin Genet Dev 21:80–85. doi:10.1016/j.gde.2010.11.001 PubMedCrossRef

18.

Troester MA, Lee MH, Carter M et al (2009) Activation of host wound responses in breast cancer microenvironment. Clin Cancer Res 15:7020–7028. doi:10.1158/1078-0432.CCR-09-1126 PubMedCrossRef

19.

Hu Z, Fan C, Oh DS et al (2006) The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 7:96. doi:10.1186/1471-2164-7-96 PubMedCrossRef

20.

Zhang Y, Szustakowski J, Schinke M (2009) Bioinformatics analysis of microarray data. Methods Mol Biol 573:259–284. doi:10.1007/978-1-60761-247-6_15 PubMedCrossRef

21.

Reimers M, Carey VJ (2006) Bioconductor: an open source framework for bioinformatics and computational biology. Methods Enzymol 411:119–134. doi:10.1016/S0076-6879(06)11008-3 PubMedCrossRef

22.

Greenland S (2008) Introduction to regression modeling. In: Rothman JK, Greenland S, Lash TL (eds) Modern epidemiology, 3rd edn. Lippincott Williams & Wilkins, Philadephia, pp 420–421

23.

Du X, Tang Y, Xu H et al (2006) Genomic profiles for human peripheral blood T cells, B cells, natural killer cells, monocytes, and polymorphonuclear cells: comparisons to ischemic stroke, migraine, and Tourette syndrome. Genomics 87:693–703. doi:10.1016/j.ygeno.2006.02.003 PubMedCrossRef

24.

Klimcakova E, Roussel B, Kovacova Z et al (2011) Macrophage gene expression is related to obesity and the metabolic syndrome in human subcutaneous fat as well as in visceral fat. Diabetologia 54:876–887. doi:10.1007/s00125-010-2014-3 PubMedCrossRef

25.

Subramanian A, Tamayo P, Mootha VK et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102:15545–15550. doi:10.1073/pnas.0506580102 PubMedCrossRef

26.

GSEA user guide http://www.broadinstitute.org/gsea/doc/GSEAUserGuideFrame.html. Accessed 03 Aug 2011

27.

Flegal KM, Carroll MD, Ogden CL et al (2010) Prevalence and trends in obesity among US adults, 1999–2008. JAMA 303:235–241. doi:10.1001/jama.2009.2014 PubMedCrossRef

28.

Vandeweyer E, Hertens D (2002) Quantification of glands and fat in breast tissue: an experimental determination. Ann Anat 184:181–184PubMedCrossRef

29.

Frayn KN, Karpe F, Fielding BA et al (2003) Integrative physiology of human adipose tissue. Int J Obes Relat Metab Disord 27:875–888. doi:10.1038/sj.ijo.0802326 PubMedCrossRef

30.

Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444:860–867. doi:10.1038/nature05485 PubMedCrossRef

31.

Nishimura S, Manabe I, Nagasaki M et al (2007) Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels. Diabetes 56:1517–1526. doi:10.2337/db06-1749 PubMedCrossRef

32.

Nishimura S, Manabe I, Nagasaki M et al (2008) In vivo imaging in mice reveals local cell dynamics and inflammation in obese adipose tissue. J Clin Invest 118:710–721. doi:10.1172/JCI33328 PubMed

33.

Suganami T, Ogawa Y (2010) Adipose tissue macrophages: their role in adipose tissue remodeling. J Leukoc Biol 88:33–39. doi:10.1189/jlb.0210072 PubMedCrossRef

34.

Weisberg SP, Hunter D, Huber R et al (2006) CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 116:115–124. doi:10.1172/JCI24335 PubMedCrossRef

35.

Kanda H, Tateya S, Tamori Y et al (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116:1494–1505. doi:10.1172/JCI26498 PubMedCrossRef

36.

Fain JN (2010) Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review. Mediators Inflamm 2010:513948. doi:10.1155/2010/513948 PubMedCrossRef

37.

Weisberg SP, McCann D, Desai M et al (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796–1808. doi:10.1172/JCI19246 PubMed

38.

Korkaya H, Liu S, Wicha MS (2011) Regulation of cancer stem cells by cytokine networks: Attacking cancers inflammatory roots. Clin Cancer Res. doi:10.1158/1078-0432.CCR-10-2743

39.

Aupperlee MD, Drolet AA, Durairaj S et al (2009) Strain-specific differences in the mechanisms of progesterone regulation of murine mammary gland development. Endocrinology 150:1485–1494. doi:10.1210/en.2008-1459 PubMedCrossRef

40.

Asselin-Labat ML, Vaillant F, Sheridan JM et al (2010) Control of mammary stem cell function by steroid hormone signalling. Nature 465:798–802. doi:10.1038/nature09027 PubMedCrossRef

41.

Li Y, Welm B, Podsypanina K et al (2003) Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci U S A 100:15853–15858. doi:10.1073/pnas.2136825100 PubMedCrossRef

42.

Ojalvo LS, Whittaker CA, Condeelis JS et al (2010) Gene expression analysis of macrophages that facilitate tumor invasion supports a role for Wnt-signaling in mediating their activity in primary mammary tumors. J Immunol 184:702–712. doi:10.4049/jimmunol.0902360 PubMedCrossRef

43.

Lau YS, Danks L, Sun SG et al (2007) RANKL-dependent and RANKL-independent mechanisms of macrophage-osteoclast differentiation in breast cancer. Breast Cancer Res Treat 105:7–16. doi:10.1007/s10549-006-9438-y PubMedCrossRef

44.

Dupuy A, Simon RM (2007) Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting. J Natl Cancer Inst 99:147–157. doi:10.1093/jnci/djk018 PubMedCrossRef

45.

Poole C (2001) Low P-values or narrow confidence intervals: which are more durable? Epidemiology 12:291–294PubMedCrossRef

46.

Furlotte NA, Kang HM, Ye C et al (2011) Mixed-model coexpression: calculating gene coexpression while accounting for expression heterogeneity. Bioinformatics 27:i288–i294. doi:10.1093/bioinformatics/btr221 PubMedCrossRef

47.

Teschendorff AE, Zhuang J, Widschwendter M (2011) Independent surrogate variable analysis to deconvolve confounding factors in large-scale microarray profiling studies. Bioinformatics 27:1496–1505. doi:10.1093/bioinformatics/btr171 PubMedCrossRef

48.

Park SK, Prolla TA (2005) Gene expression profiling studies of aging in cardiac and skeletal muscles. Cardiovasc Res 66:205–212. doi:10.1016/j.cardiores.2005.01.005 PubMedCrossRef

49.

Park SK, Kim K, Page GP et al (2009) Gene expression profiling of aging in multiple mouse strains: identification of aging biomarkers and impact of dietary antioxidants. Aging Cell 8:484–495. doi:10.1111/j.1474-9726.2009.00496.x PubMedCrossRef

50.

Morris PG, Hudis CA, Giri D et al (2011) Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Cancer Prev Res (Phila) 4:1021–1029. doi:10.1158/1940-6207.CAPR-11-0110 CrossRef

51.

Subbaramaiah K, Howe LR, Bhardwaj P et al (2011) Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland. Cancer Prev Res (Phila) 4:329–346. doi:10.1158/1940-6207.CAPR-10-0381 CrossRef

52.

Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357:539–545. doi:10.1016/S0140-6736(00)04046-0 PubMedCrossRef

53.

Mantovani A, Sozzani S, Locati M et al (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23:549–555PubMedCrossRef

54.

Lumeng CN, Bodzin JL, Saltiel AR (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117:175–184. doi:10.1172/JCI29881 PubMedCrossRef

55.

Lumeng CN, DelProposto JB, Westcott DJ et al (2008) Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. Diabetes 57:3239–3246. doi:10.2337/db08-0872 PubMedCrossRef

56.

Chazenbalk G, Bertolotto C, Heneidi S et al (2011) Novel pathway of adipogenesis through cross-talk between adipose tissue macrophages, adipose stem cells and adipocytes: evidence of cell plasticity. PLoS One 6:e17834. doi:10.1371/journal.pone.0017834 PubMedCrossRef

Title: Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression
Authors: Xuezheng Sun
Patricia Casbas-Hernandez
Carol Bigelow
Liza Makowski
D. Joseph Jerry
Sallie Smith Schneider
Melissa A. Troester
Publication date: 01-02-2012
Publisher: Springer US
Published in: Breast Cancer Research and Treatment / Issue 3/2012
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-011-1789-3

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2012

Erratum to: Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis

Loss of Yes-associated protein (YAP) expression is associated with estrogen and progesterone receptors negativity in invasive breast carcinomas

bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer

Neoadjuvant chemotherapy in ER+ HER2− breast cancer: response prediction based on immunohistochemical and molecular characteristics

Daintain/AIF-1 promotes breast cancer cell migration by up-regulated TNF-α via activate p38 MAPK signaling pathway

Prediction of menopausal status from estrogen-related gene expression in benign breast tissue

Keynote webinar | Spotlight on antibody–drug conjugates in cancer